Premium
Phenotypic Differences between Human Blood Monocyte Subpopulations in Psoriasis and Atopic Dermatitis
Author(s) -
Zheng Min,
Mrowietz Ulrich
Publication year - 1997
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.1997.tb02807.x
Subject(s) - monocyte , cd14 , atopic dermatitis , immunology , psoriasis , cd16 , medicine , phenotype , hla dr , hla dq , antigen , biology , immune system , gene , cd3 , biochemistry , genotype , cd8 , haplotype
Peripheral blood monocytes seem to be of importance in the initiation and maintenance of cutaneous inflammatory disorders such as psoriasis and atopic dermatitis. Functional abnormalities of monocytes have been observed in both diseases. We sought to determine whether these abnormalities are reflected by an altered phenotypic expression of functionally active surface molecules. Peripheral blood monocyte subsets varying in cellular density and cell size from patients with psoriasis and atopic dermatitis were investigated using FACS analysis employing a panel of monoclonal antibodies (CD14, CD16, HLA‐DR, HLA‐DQ, FcɛRII, IL‐2R, ICAM‐1, CR3). Furthermore, the modulation of expression by interferon‐γ in monocyte subsets from patients was compared to normal controls. The results show that HLA‐DR and ‐DQ expression on monocyte subsets in psoriatic patients was significantly decreased; “large” monocytes expressed significantly less HLA‐DR than “small” monocyte subpopulations. Decreased HLA‐DR and ‐DQ expression could be upregulated by incubation of psoriatic monocytes with IFNγ. In atopic dermatitis, a different phenotype pattern of monocyte subsets was demonstrated: HLA‐DR expression and HLA‐DQ expression were both decreased in both “large” and “small” monocytes as compared to normal controls. However, there were no significant differences in HLA‐DR and HLA‐DQ expression between “large” and “small” monocyte subpopulations in atopic dermatitis. Moreover, the ICAM‐1 and IL‐2R expression of “large” and “small” monocyte subpopulations was significantly decreased in atopic patients from levels in normal controls and psoriatic patients. The altered expression of HLA‐DR, ‐DQ, ICAM‐1 and IL‐2R could be upregulated by incubation of atopic monocytes with IFNγ. In addition, there was a significant increase in the percentage of monocytes in the differential count of patients with psoriasis or atopic dermatitis. We conclude that the differential phenotype pattern of surface molecules on monocytes in psoriasis and atopic dermatitis may reflect an abnormal monocyte maturation/differentiation state. This may explain the functional abnormalities of monocytes observed in patients with psoriasis and atopic dermatitis.